GlassScriptPhysician profile
Nicole May
NPI 1205338548
$2,818.79
in general payments reported to CMS, 2019-2025
13 companies · $934 in 2025
The $934 reported for 2025 was more than what 86% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $544 · 2022: $672 · 2023: $179 · 2024: $490 · 2025: $934.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,603.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,603.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $943.28 | 2022-2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $566.98 | 2021-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $457.39 | 2021-2025 | Farxiga |
| Abbott Laboratories | $223.70 | 2021-2024 | Aveir |
| Biotronik INC. | $154.89 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $111.96 | 2023 | Camzyos |
| Novo Nordisk INC | $105.94 | 2024 | |
| Abiomed | $82.21 | 2022 | |
| Medtronic, INC. | $54.00 | 2021 | |
| Novartis Pharmaceuticals Corporation | $49.61 | 2024 | |
| Lilly USA, LLC | $24.45 | 2025 | Zepbound |
| Boston Scientific Corporation | $24.43 | 2025 | Watchman Flx |
| Biotronik Nro, INC. | $19.95 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole May listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.